Atherosclerosis
Volume 213, Issue 2 , Pages 532-538 , December 2010

Common clinical practice versus new PRIM score in predicting coronary heart disease risk

  • Ruth Frikke-Schmidt

      Affiliations

    • Department of Clinical Biochemistry, Rigshospitalet, Denmark
    • Copenhagen University Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    • Corresponding Author InformationCorresponding author at: Dept. of Clinical Biochemistry, Section for Molecular Genetics, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. Tel.: +45 3545 4348; fax: +45 3545 4160.
    • ,
  • Anne Tybjærg-Hansen

      Affiliations

    • Department of Clinical Biochemistry, Rigshospitalet, Denmark
    • The Copenhagen City Heart Study, Bispebjerg Hospital, Denmark
    • Copenhagen University Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    • ,
  • Peter Schnohr

      Affiliations

    • The Copenhagen City Heart Study, Bispebjerg Hospital, Denmark
    • Copenhagen University Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    • ,
  • Gorm B. Jensen

      Affiliations

    • The Copenhagen City Heart Study, Bispebjerg Hospital, Denmark
    • Copenhagen University Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
    • ,
  • Børge G. Nordestgaard

      Affiliations

    • The Copenhagen City Heart Study, Bispebjerg Hospital, Denmark
    • Department of Clinical Biochemistry, Herlev Hospital, Denmark
    • Copenhagen University Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

Received 26 October 2009 ,Revised 30 June 2010 ,Accepted 19 July 2010.

References 

  1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997;349:1269–1276
  2. Rosamond W, Flegal K, Friday G, et al. Heart Disease and Stroke Statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69–171
  3. Wilson PWF, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
  4. Graham I. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis. 2007;194:1–45
  5. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335:136
  6. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  7. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score. JAMA. 2007;297:611–619
  8. Dyson G, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A, Sing CF. An application of the Patient Rule Induction Method for evaluating the contribution of the apolipoprotein E and lipoprotein lipase genes to predicting ischemic heart disease. Genet Epidemiol. 2007;31:515–527
  9. Frikke-Schmidt R, Nordestgaard BG, Stene MC, et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA. 2008;299:2524–2532
  10. Nordestgaard BG, Benn M, Schnohr P, Tybjærg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299–308
  11. Appleyard M, Hansen AT, Jensen G, Schnohr P, Nyboe J. The Copenhagen City Heart Study. Østerbroundersøgelsen. A book of tables with data from the first examination (1976–78) and a five year follow-up (1981–83). The Copenhagen City Heart Study Group. Scand J Soc Med Suppl. 1989;41:1–160
  12. Julian DG, Bertrand ME, Hjalmarson A, et al. Management of stable angina pectoris – recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 1997;18:394–413
  13. Petri CN. Decrease in the frequency of autopsies in Denmark after the introduction of a new autopsy act. Qual Assur Health Care. 1993;5:315–318
  14. Friedman JH, Fisher NI. Bump hunting in high-dimensional data. Stat Comput. 1999;9:123–143
  15. Dyson G, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A, Sing CF. Modifications to the Patient Rule-Induction Method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease. Genet Epidemiol. 2009;33:317–324
  16. Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003
  17. Blumenthal RS, Michos ED, Nasir K. Further improvements in CHD risk prediction for women. JAMA. 2007;297:641–643
  18. Kannel WB, D’Agostino RB, Sullivan L, Wilson PWF. Concept and usefulness of cardiovascular risk profiles. Am Heart J. 2004;148:16–26
  19. D’Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary Heart Disease Prediction Scores. Results of a multiple ethnic group investigation. JAMA. 2001;286:180–187
  20. Hippisley-Cox J, Couplan C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335:136
  21. Sing CF, Stengard JH, Kardia SLR. Genes, environment, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23:1190–1196
  22. Clark AG, Boerwinkle E, Hixson JE, Sing CF. Determinants of the success of whole-genome association testing. Genome Res. 2005;15:1463–1467
  23. Benfey PN, Mitchell-Olds T. From genotypes to phenotype: systems biology meets natural variation. Science. 2008;320:495–497
  24. Schnohr P, Jensen JS, Scharling H, Nordestgaard BG. Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12,000 men and women from The Copenhagen City Heart Study. Eur Heart J. 2002;23:620–626
  25. Ducimetiere P, Richard JL, Cambien F, Rakotovao R, Claude R. Coronary heart disease in middle-aged Frenchmen. Comparisons between Paris Prospective Study, Seven Countries Study, and Pooling Project. Lancet. 1980;1:1346–1350
  26. Shaper AG, Pocock SJ, Walker M, et al. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ. 1981;283:179–186
  27. Wilhelmsen L, Berglund G, Elmfeldt D, et al. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J. 1986;7:279–288
  28. Njolstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction: a 12-year follow-up of the Finnmark Study. Circulation. 1996;93:450–456
  29. Vartiainen E, Jousilahti P, Alfthan G, et al. Cardiovascular risk factor changes in Finland, 1972–1997. Int J Epidemiol. 2000;29:49–56

PII: S0021-9150(10)00573-3

doi: 10.1016/j.atherosclerosis.2010.07.028

Atherosclerosis
Volume 213, Issue 2 , Pages 532-538 , December 2010

Article Tools

* Image Usage & Resolution